Bharat Biotech International Limited

bharatbiotech.com

Bharat Biotech International Limited is a multidimensional biotechnology company specializing in product-oriented research and development leading to the manufacture of vaccines and biotherapeutics. Bharat Biotech was established in the year 1996 by Dr. Krishna M. Ella and Mrs. Suchitra K. Ella.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

BIOTECHS WORKING CLOSELY & FEVERISHLY WITH CDC FOR COVID-19 VACCINE DEVELOPMENT

PR Newswire | April 07, 2020

news image

Many companies searching for an effective therapy or vaccine for the present world health crisis are focusing on creating a vaccine from the immune system. Key to the race to develop a vaccine for the new coronavirus is a technology that uses the virus' genetic code to essentially persuade your body to make its own vaccine. This technique is faster than egg-based manufacturing, which produces the majority of annual flu vaccines… And it's enabling a possible vaccine for the new cor...

Read More

Medical

OLIX PHARMACEUTICALS SUBSIDIARY MCUREX ANNOUNCES MRNA TECHNOLOGY COLLABORATION WITH TOOLGEN FOR RARE EYE DISEASE

OliX | June 20, 2022

news image

OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, today announced that the Company’s subsidiary mCureX Therapeutics, Inc. has recently signed a contract for joint research with ToolGen, Inc. to advance the development of gene therapy for rare eye diseases, leveraging mCureX’s mRNA technology. mCureX, specializing in mRNA vaccines and therapeutics, and ToolGen, having expertise in therapeutic gene-editing technologies, have been in active discussions...

Read More

Industrial Impact

MODERN MEADOW AND BASF COLLABORATE TO CREATE A NEW INNOVATIVE ANIMAL-FREE ENRICHED MATERIAL

PRnewswire | July 05, 2023

news image

Modern Meadow, a purpose-driven biotechnology company, is proud to announce its strategic partnership with BASF, a leading global chemical company, to embark on a collaboration to revolutionize the material industry. This strategic collaboration will bring together the cutting-edge biofabrication expertise of Modern Meadow with BASF's renowned Ultramid® Ccycled® material, paving the way for the creation of a modern, sustainable, and animal-free material of the future. ...

Read More

K-COSMECEUTICAL COMPANY DERMAFIRM USA, INC. OFFICIALLY ANNOUNCED ITS U.S. EXPANSION

PR Newswire | July 22, 2020

news image

Today the K-cosmeceutical company Dermafirm USA, Inc., the U.S. arm of South Korea's Dermafirm Inc., is officially announcing its U.S. expansion. Plans are to formally introduce its U.S. leadership team on July 28th, at a private, virtual event. During the event, the company will kick off a movement with a mission to embrace scientific innovation, educate consumers on clean, natural and healthy DIY skincare options and ultimately empower users to perform these skincare regimens safely at hom...

Read More
news image

BIOTECHS WORKING CLOSELY & FEVERISHLY WITH CDC FOR COVID-19 VACCINE DEVELOPMENT

PR Newswire | April 07, 2020

Many companies searching for an effective therapy or vaccine for the present world health crisis are focusing on creating a vaccine from the immune system. Key to the race to develop a vaccine for the new coronavirus is a technology that uses the virus' genetic code to essentially persuade your body to make its own vaccine. This technique is faster than egg-based manufacturing, which produces the majority of annual flu vaccines… And it's enabling a possible vaccine for the new cor...

Read More
news image

Medical

OLIX PHARMACEUTICALS SUBSIDIARY MCUREX ANNOUNCES MRNA TECHNOLOGY COLLABORATION WITH TOOLGEN FOR RARE EYE DISEASE

OliX | June 20, 2022

OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, today announced that the Company’s subsidiary mCureX Therapeutics, Inc. has recently signed a contract for joint research with ToolGen, Inc. to advance the development of gene therapy for rare eye diseases, leveraging mCureX’s mRNA technology. mCureX, specializing in mRNA vaccines and therapeutics, and ToolGen, having expertise in therapeutic gene-editing technologies, have been in active discussions...

Read More
news image

Industrial Impact

MODERN MEADOW AND BASF COLLABORATE TO CREATE A NEW INNOVATIVE ANIMAL-FREE ENRICHED MATERIAL

PRnewswire | July 05, 2023

Modern Meadow, a purpose-driven biotechnology company, is proud to announce its strategic partnership with BASF, a leading global chemical company, to embark on a collaboration to revolutionize the material industry. This strategic collaboration will bring together the cutting-edge biofabrication expertise of Modern Meadow with BASF's renowned Ultramid® Ccycled® material, paving the way for the creation of a modern, sustainable, and animal-free material of the future. ...

Read More
news image

K-COSMECEUTICAL COMPANY DERMAFIRM USA, INC. OFFICIALLY ANNOUNCED ITS U.S. EXPANSION

PR Newswire | July 22, 2020

Today the K-cosmeceutical company Dermafirm USA, Inc., the U.S. arm of South Korea's Dermafirm Inc., is officially announcing its U.S. expansion. Plans are to formally introduce its U.S. leadership team on July 28th, at a private, virtual event. During the event, the company will kick off a movement with a mission to embrace scientific innovation, educate consumers on clean, natural and healthy DIY skincare options and ultimately empower users to perform these skincare regimens safely at hom...

Read More